DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

De Cock E, Pan I, Sandoval M et al.
Healthcare professionalsʼ perceptions of the impact on clinical management of switching from the intravenous to the subcutaneous formulation of trastuzumab. European Breast Cancer Conference 2014, Glasgow, Abstr. 42.

Download Bibliographical Data

Search in: